Basecamp Wealth Advisors’s Treace Medical Concepts TMCI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$959 Buy
241
+13
+6% +$36 ﹤0.01% 1530
2026
Q1
$306 Buy
+228
New +$454 ﹤0.01% 1817

Other funds holding TMCI

Basecamp Wealth Advisors's TMCI Position: Q2 2026 in Review

Basecamp Wealth Advisors increased its Treace Medical Concepts (TMCI) stake by 5.7% in Q2 2026, buying an estimated $36 and bringing the position to 241 shares worth $959. The position accounts for ﹤0.01% of the portfolio, ranked #1530.

Basecamp Wealth Advisors first reported a position in TMCI in Q1 2026 and has held it in 2 quarters since. 117 funds tracked by Wall St. Rank hold TMCI as of Q2 2026.

  • Basecamp Wealth Advisors held 241 shares of Treace Medical Concepts worth $959 as of Q2 2026.
  • Basecamp Wealth Advisors bought 13 Treace Medical Concepts shares in Q2 2026, an estimated $36.
  • Treace Medical Concepts made up ﹤0.01% of Basecamp Wealth Advisors's portfolio in Q2 2026, its #1530 holding.
  • Basecamp Wealth Advisors first reported a position in Treace Medical Concepts in Q1 2026 and has held it in 2 quarters since.
  • 117 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q2 2026.

Based on Basecamp Wealth Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.